| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on April 20, 2004
Revised on October 19, 2004
Accepted on October 21, 2004
From the Cardiovascular Division (R.S.H., F.C., T.J.H., J.C.K., M.G., M.A.) and Randall Division of Cell and Molecular Biophysics (M.G.), King’s College London, London, UK; and the Department of Physical Biochemistry (G.F.), Max-Planck Institute of Molecular Physiology, Dortmund, Germany.
* To whom correspondence should be addressed. E-mail: metin.avkiran{at}kcl.ac.uk.
Protein kinase D (PKD) is a serine kinase whose myocardial substrates are unknown. Yeast 2-hybrid screening of a human cardiac library, using the PKD catalytic domain as bait, identified cardiac troponin I (cTnI), myosin-binding protein C (cMyBP-C), and telethonin as PKD-interacting proteins. In vitro phosphorylation assays revealed PKD-mediated phosphorylation of cTnI, cMyBP-C, and telethonin, as well as myomesin. Peptide mass fingerprint analysis of cTnI by liquid chromatography-coupled mass spectrometry indicated PKD-mediated phosphorylation of a peptide containing Ser22 and Ser23, the protein kinase A (PKA) targets. Ser22 and Ser23 were replaced by Ala, either singly (Ser22Ala or Ser23Ala) or jointly (Ser22/23Ala), and the troponin complex reconstituted in vitro, using wild-type or mutated cTnI together with wild-type cardiac troponin C and troponin T. PKD-mediated cTnI phosphorylation was reduced in complexes containing Ser22Ala or Ser23Ala cTnI and completely abolished in the complex containing Ser22/23Ala cTnI, indicating that Ser22 and Ser23 are both targeted by PKD. Furthermore, troponin complex containing wild-type cTnI was phosphorylated with similar kinetics and stoichiometry (
2 mol phosphate/mol cTnI) by both PKD and PKA. To determine the functional impact of PKD-mediated phosphorylation, Ca2+ sensitivity of tension development was studied in a rat skinned ventricular myocyte preparation. PKD-mediated phosphorylation did not affect maximal tension but produced a significant rightward shift of the tension-pCa relationship, indicating reduced myofilament Ca2+ sensitivity. At submaximal Ca2+ activation, PKD-mediated phosphorylation also accelerated isometric crossbridge cycling kinetics. Our data suggest that PKD is a novel mediator of cTnI phosphorylation at the PKA sites and may contribute to the regulation of myofilament function.
This article has been cited by other articles:
![]() |
R. Zhang, J. Yang, J. Zhu, and X. Xu Depletion of zebrafish Tcap leads to muscular dystrophy via disrupting sarcomere-membrane interaction, not sarcomere assembly Hum. Mol. Genet., November 1, 2009; 18(21): 4130 - 4140. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. O. Rybin, J. Guo, and S. F. Steinberg Protein Kinase D1 Autophosphorylation via Distinct Mechanisms at Ser744/Ser748 and Ser916 J. Biol. Chem., January 23, 2009; 284(4): 2332 - 2343. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Zabrouskov, Y. Ge, J. Schwartz, and J. W. Walker Unraveling Molecular Complexity of Phosphorylated Human Cardiac Troponin I by Top Down Electron Capture Dissociation/Electron Transfer Dissociation Mass Spectrometry Mol. Cell. Proteomics, October 1, 2008; 7(10): 1838 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jaggi, S. C. Chauhan, C. Du, and K.C. Balaji Bryostatin 1 modulates {beta}-catenin subcellular localization and transcription activity through protein kinase D1 activation Mol. Cancer Ther., September 1, 2008; 7(9): 2703 - 2712. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ozgen, M. Obreztchikova, J. Guo, H. Elouardighi, G. W. Dorn II, B. A. Wilson, and S. F. Steinberg Protein Kinase D Links Gq-coupled Receptors to cAMP Response Element-binding Protein (CREB)-Ser133 Phosphorylation in the Heart J. Biol. Chem., June 20, 2008; 283(25): 17009 - 17019. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mazzone, P. R. Strege, D. J. Tester, C. E. Bernard, G. Faulkner, R. De Giorgio, J. C. Makielski, V. Stanghellini, S. J. Gibbons, M. J. Ackerman, et al. A Mutation in Telethonin Alters Nav1.5 Function J. Biol. Chem., June 13, 2008; 283(24): 16537 - 16544. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-S. Kim, J. Fielitz, J. McAnally, J. M. Shelton, D. D. Lemon, T. A. McKinsey, J. A. Richardson, R. Bassel-Duby, and E. N. Olson Protein Kinase D1 Stimulates MEF2 Activity in Skeletal Muscle and Enhances Muscle Performance Mol. Cell. Biol., June 1, 2008; 28(11): 3600 - 3609. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Maturana, S. Walchli, M. Iwata, S. Ryser, J. Van Lint, M. Hoshijima, W. Schlegel, Y. Ikeda, K. Tanizawa, and S. Kuroda Enigma homolog 1 scaffolds protein kinase D1 to regulate the activity of the cardiac L-type voltage-gated calcium channel Cardiovasc Res, June 1, 2008; 78(3): 458 - 465. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sadayappan, N. Finley, J. W. Howarth, H. Osinska, R. Klevitsky, J. N. Lorenz, P. R. Rosevear, and J. Robbins Role of the acidic N' region of cardiac troponin I in regulating myocardial function FASEB J, April 1, 2008; 22(4): 1246 - 1257. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Bossuyt, K. Helmstadter, X. Wu, H. Clements-Jewery, R. S. Haworth, M. Avkiran, J. L. Martin, S. M. Pogwizd, and D. M. Bers Ca2+/Calmodulin-Dependent Protein Kinase II{delta} and Protein Kinase D Overexpression Reinforce the Histone Deacetylase 5 Redistribution in Heart Failure Circ. Res., March 28, 2008; 102(6): 695 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden Sarcomeric dysfunction in heart failure Cardiovasc Res, March 1, 2008; 77(4): 649 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fielitz, M.-S. Kim, J. M. Shelton, X. Qi, J. A. Hill, J. A. Richardson, R. Bassel-Duby, and E. N. Olson Requirement of protein kinase D1 for pathological cardiac remodeling PNAS, February 26, 2008; 105(8): 3059 - 3063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avkiran, A. J. Rowland, F. Cuello, and R. S. Haworth Protein Kinase D in the Cardiovascular System: Emerging Roles in Health and Disease Circ. Res., February 1, 2008; 102(2): 157 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Wu and R. J. Solaro Protein Kinase C {zeta}: A NOVEL REGULATOR OF BOTH PHOSPHORYLATION AND DE-PHOSPHORYLATION OF CARDIAC SARCOMERIC PROTEINS J. Biol. Chem., October 19, 2007; 282(42): 30691 - 30698. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Johannessen, M. P. Delghandi, A. Rykx, M. Dragset, J. R. Vandenheede, J. Van Lint, and U. Moens Protein Kinase D Induces Transcription through Direct Phosphorylation of the cAMP-response Element-binding Protein J. Biol. Chem., May 18, 2007; 282(20): 14777 - 14787. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cuello, S. C. Bardswell, R. S. Haworth, X. Yin, S. Lutz, T. Wieland, M. Mayr, J. C. Kentish, and M. Avkiran Protein Kinase D Selectively Targets Cardiac Troponin I and Regulates Myofilament Ca2+ Sensitivity in Ventricular Myocytes Circ. Res., March 30, 2007; 100(6): 864 - 873. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. McKinsey Derepression of pathological cardiac genes by members of the CaM kinase superfamily Cardiovasc Res, March 1, 2007; 73(4): 667 - 677. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Bilchick, J. G. Duncan, R. Ravi, E. Takimoto, H. C. Champion, W. D. Gao, L. B. Stull, D. A. Kass, and A. M. Murphy Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H318 - H325. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. C. Harrison, M.-S. Kim, E. van Rooij, C. F. Plato, P. J. Papst, R. B. Vega, J. A. McAnally, J. A. Richardson, R. Bassel-Duby, E. N. Olson, et al. Regulation of Cardiac Stress Signaling by Protein Kinase D1 Mol. Cell. Biol., May 15, 2006; 26(10): 3875 - 3888. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Arteaga, C. M. Warren, S. Milutinovic, A. F. Martin, and R. J. Solaro Specific enhancement of sarcomeric response to Ca2+ protects murine myocardium against ischemia-reperfusion dysfunction Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H2183 - H2192. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rozengurt, O. Rey, and R. T. Waldron Protein Kinase D Signaling J. Biol. Chem., April 8, 2005; 280(14): 13205 - 13208. [Full Text] [PDF] |
||||
![]() |
A. M. Murphy Another New Kinase Targets Troponin I Circ. Res., November 26, 2004; 95(11): 1043 - 1045. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |